Who has invested in Tremeau Pharmaceuticals?

Gurnet Point Capital are named among the investors backing Tremeau Pharmaceuticals.

Tremeau Pharmaceuticals Funding: $59M Raised, Other (2019)

Tremeau Pharmaceuticals funding overview

Tremeau Pharmaceuticals is based in Cambridge. Tremeau Pharmaceuticals has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an Other announced in January 2019. The round record for Tremeau Pharmaceuticals runs through 2019; nothing later has been disclosed. Investors on record include Gurnet Point Capital.

Tremeau Pharmaceuticals at a glance

Total raised: $59M
Latest round: Other
Latest round date: January 2019
Headquarters: Cambridge
Notable investors: Gurnet Point Capital

Frequently asked about Tremeau Pharmaceuticals funding

How much has Tremeau Pharmaceuticals raised?: Tremeau Pharmaceuticals has raised $59M in total disclosed funding across the rounds on record.
Who has invested in Tremeau Pharmaceuticals?: Gurnet Point Capital are named among the investors backing Tremeau Pharmaceuticals.
What was the latest Tremeau Pharmaceuticals funding round?: The most recent disclosed round is an Other, announced in January 2019.
Where is Tremeau Pharmaceuticals based?: Tremeau Pharmaceuticals is based in Cambridge.
When did Tremeau Pharmaceuticals last raise?: The last disclosed Tremeau Pharmaceuticals round closed in January 2019 at Other.

Tremeau Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Tremeau Pharmaceuticals Funding: $59M Raised, Other (2019)

Tremeau Pharmaceuticals funding overview

Tremeau Pharmaceuticals at a glance

Frequently asked about Tremeau Pharmaceuticals funding

Companies related to Tremeau Pharmaceuticals (22)

Browse related funding lists (4)